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Abstract
Cerebral arteriovenous malformations (cAVMs) are the rare neurosurgical 
emergency. cAVM is an abnormal vascular web, composed of nidus, feeding artery 
and draining veins. It commonly occurs in the supratentorial area of the brain. The 
common grading system used in cAVM is Spetzler-Martin grading, which takes into 
consideration the size of nidus, the location of cAVM and the venous drainage. The 
cAVMs may develop flow and pressure-related aneurysms, which will increase the 
morbidity and mortality in these patients. cAVMs vary in size and undergo growth, 
remodeling and rarely regression. Most of the cAVMs are asymptomatic, but the 
common presentation are headache, seizure, intracerebral hemorrhage or focal 
neurological deficit. The cerebral angiography remains the gold standard for the 
diagnosis of cAVM. Management of the cAVM includes medical therapy, surgical 
excision, radiosurgery and embolization.
Keywords: cerebral angiography, headache, embolization, focal neurological deficit, 
intracerebral hemorrhage, medical therapy, radiosurgery, seizers, surgical excision, 
Spetzler-Martin grading
1. Introduction
1.1 Definition
Cerebral arteriovenous malformations (cAVMs) are the vascular abnormality 
composed of a complex, tangled web of afferent arteries and draining veins linked 
by an abnormal dysplastic intervening capillary bed or no capillary bed (Figure 1). 
The raptured cAVM is a neurosurgical emergency requiring team management 
approach including neurosurgeons, neuro-interventional radiologist, neuro- 
anaesthesiologist and an intensivist.
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2. Epidemiology
Cerebral arteriovenous malformations are rare, found in around 0.1% of the 
population and one-tenth (1/10th) of the incidence of the brain aneurysms. 
About 15% of cAVMs remain asymptomatic based on autopsy series. The 
majority (90%) of cAVMs are found in the supratentorial region, the remain-
ing 10% occur in the posterior fossa. cAVMs commonly occur as single lesions, 
and in 9% of the patients, there are multiple AVMs [1, 2]. cAVM has no gender 
preference.
cAVM causes subarachnoid hemorrhages in 9% of the patients. The mean age of 
presentation is 30–40 years; 3% of young patients had stroke due to cAVM. It also 
causes primary intracerebral hemorrhage in 33% of young adults [3].
3. Classifications
cAVM is classified as follows:
1. Luessenhop-Gennarelli anatomical grading
2. Spetzler-Martin grading (Table 1)/supplementary Spetzler-Martin grading 
(Table 2)
Figure 1. 
Cerebral arteriovenous malformation.
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3. Nataf grading (Table 3)
4. Vienna classification (Table 4).
Size of cAVM
0–3 cm 1
3.1–6.0 cm 2
>6 cm 3
Location of cAVM: eloquent areas (sensorimotor, language, visual, thalamus, hypothalamus, internal capsule, 
brain stem, cerebellar peduncles and deep cerebellar nuclei)
Non-eloquent brain area 0
Eloquent brain area 1
Deep venous drainage
Absent 0
Present 1
AVM grade = size + eloquence + deep component
Table 1. 
Spetzler-Martin grading scale for cAVM.
Size of cAVM Patient’s age (years)
0–3 cm 1 <20
3.1–6.0 cm 2 20–40
>6 cm 3 >40
Location of cAVM (eloquence area) Compactness
No 0 Yes
Yes 1 No
Venous drainage Bleeding
Superficial 0 Yes
Deep 1 No
Table 2. 
Supplementary Spetzler-Martin or Lawton-Young cAVM grading scale.
Grade I No risk factor for bleeding
Grade Ia With venous recruitment
Grade Ib Without venous recruitment grade
Grade II Venous stenosis or venous reflux
Grade III Deep venous drainage only
Grade IV Intra- or juxta-nidal aneurysm
According to this grading system, there is 13% of hemorrhage in grade Ia, in grade Ib 38%, in grade II 48% and in 
grade III and IV risk of hemorrhage 90% [7].
Table 3. 
Nataf grading.
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3.1 Luessenhop-Gennarelli grading
This is the anatomical grading of supratentorial cAVM described in 1977, 
according to the degrees of surgical difficulty for total obliteration, graded into I–IV. 
Luessenhop-Gennarelli grading of cAVM is based upon the number of directly 
participating arteries for which there is a standardized nomenclature [4].
3.2 Spetzler-Martin (S-M) grading
In 1986 Spetzler and Martin graded cAVMs according to location, size and deep 
venous drainage, into the following five grades [5]:
1. Low-grade AVM: Grade I, grade II and grade III
2. High-grade AVM: Grade IV and grade V
3. Inoperable lesions: Grade VI (supplementary Spetzler-Martin (S-M Supp)).
The disadvantages of S-M grading of cAVM are definition of eloquence, lack 
of consideration for nidus compactness, not useful for posterior fossa AVM, only 
applicable for surgical outcome and grade III in homogeneity.
Supplementary Spetzler-Martin or Lawton-Young grading scale for cAVM was 
described in 2010, apart from the risk factors included in S-M grading; this S-M 
Supp grading system includes factors affecting the patient’s outcome, namely, age, 
bleeding or compactness of the cAVMs (Table 2) [6]. Kim et al. from their cohort 
multicentre study concluded that S-M Supp grading system works better than the 
S-M grading for operability decisions and cut-off value for operability is S-M Supp 
scale of 6. S-M Supp also gives better post-operative neurological outcome predict-
ability than the S-M score.
3.3 Nataf grading
In this 4-point grading, five angiographic parameters are used for the determi-
nants of the bleeding risk.
3.4 Vienna classification
This classification is helpful in choosing the mode of treatment.
4. Morphology and type cAVM
Depending on the type and morphology, cAVM (Figure 2) is divided into the 
following (Tables 5 and 6):
Gr 0 Gr I Gr II Gr III
Feeders Pial Pial + perforators Perforator
Number of feeders 1–2 >2
Nidus (cm) <2 2–4 >4
Table 4. 
Vienna classification.
5Cerebral Arteriovenous Malformation from Classification to the Management
DOI: http://dx.doi.org/10.5772/intechopen.86659
5. Pathophysiology
The pathogenesis of cAVMs is not well understood; they are considered con-
genital and can undergo growth, remodeling or regression over the period. The 
Figure 2. 
Details of cAVM and associated aneurysms.
Cryptic Absent on angiogram/surgery/pathology
Occult Absent on angiogram/surgery/seen only in pathology examination
According to the size of cAVM
Micro-AVM <1 cm
Small AVM <2.5 cm
Moderate AVM 2.5–5 cm
Large AVM >5 cm
Table 5. 
Morphology of cAVM.
Type Nature Pathological features of the 
vessel wall
Treatment modality
Intranidal Pseudo-aneurysm Disruption of internal elastic 
lamina (IEL)
Embolization
Distal 
flow-related
Saccular aneurysm, 
arising from the 
arterial trunk
Disruption of IEL, deficiency in 
the smooth muscle layer
The aneurysm and the 
parent artery were occluded 
with Onyx at the same 
sitting
Proximal 
flow-related
Segmental ectasia Stretched/fragmented IEL: no 
luminal thrombus
Coiling for symptomatic 
lesion
Unrelated Saccular, arising 
from the Willis 
circle or a site of 
bifurcation
Disruption of the IEL Simply coiling or stent-
assisted coiling
Table 6. 
Classification of aneurysm with cAVM [8].
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size of cAVMs varies widely, and cAVM can remain clinically silent for decades. In 
cAVM blood flows directly between them without capillary bed and not interven-
ing neural parenchyma in nidus. cAVMs is a high-flow and high-pressure system. 
Particularly the small AVMs are having significantly higher pressure in the feeding 
arteries; hence the small AVMs are more lethal than the larger ones and bleed more 
frequently.
Familial cAVMs have been reported, but it is not clear whether these are coin-
cidental or indicate a familial occurrence. Angio-architecture of cAVMs is direct 
arterial to venous connections without an intervening capillary network. Both the 
arterial supply and the venous drainage may be by single or multiple vessels. The 
high-flow arteriovenous communication potentiates a variety of flow-related phe-
nomena such as the development of afferent and efferent pedicle aneurysms, which 
occur in 20–25% of patients, and arterialization of the venous limb. Aneurysms 
can be a source of bleeding with cAVMs and may indicate a grave prognosis [9]. 
Abnormal flow and a vascular steal phenomenon have been suggested to underlie 
some clinical symptoms associated with cAVMs [10]. Histopathological stud-
ies demonstrate areas of chronic ischemia and gliosis in the region of the cAVM 
malformation. Angio-structure of cAVM is typically composed of arterial feeder, 
nidus, draining vein and intervening gliotic neural parenchyma. The arterial feeder 
can be single or multiple originating from pial or perforating or dural arteries, and 
it can be a direct feeder supply as terminal branch or indirect feeder supply en-
passage. Nidus is a compact tangle of dysplastic, thin-walled vessels of varied length 
connecting feeding arteries to draining veins. cAVM nidus can either be globular 
or conical in shape and may be compact or diffuse. Within the nidus, arterial blood 
is shunted directly into draining veins without passage through a normal, high-
resistance arteriolar-capillary network.
6. Clinical presentation
cAVMs commonly present in younger age group ranging from 10 to 40 years. 
The clinical presentation of cAVM depends on the patient’s age, size, location and 
vascular features of the cAVM. These patients commonly present with headache or 
neurological deficit or convulsions or intracerebral hemorrhage.
6.1 Headache
Around 0.2% of patients with headache and normal neurologic examina-
tions were associated with cAVM [11]. Usually headache associated with cAVM 
is incidental, without any specifications. Headaches are the presenting symptom 
in approximately 15% of patients without evidence of rupture. Headache can be 
characterized as similar to migraines with lateralization to one side.
6.2 Focal neurologic deficit
This is quite an unusual presentation of cAVM. A vascular steal syndrome is 
hypothesized to be the cause for focal neurologic deficit [1].
6.3 Seizure (convulsions)
About 11–33% of cAVM patients present with convulsions, and patients with 
cortical-located, large, multiple and superficial-draining cAVMs present with 
convulsions [12]. Convulsions are focal, simple or partial complex with secondary 
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generalization. cAVM-related seizures may occur due to the overt intracranial 
hemorrhage, from the hemosiderin deposition, or secondary to venous hyperten-
sion, ischemia following steal. The cAVM location influences the seizure type and 
semiology. The 5-year seizure risk for cAVMs is found to be 8% [13].
6.4 Intracerebral hemorrhage
About 41–79% of cAVM patients present with intracerebral hemorrhage (ICH) 
(Figure 3). Children more frequently present with intracerebral hemorrhage than 
adults [14]; 23% of patients with ICH or focal neurologic deficits had a 5-year risk 
of seizures. Hemorrhage can be parenchymal, intraventricular or subarachnoid.
Patients with cAVMs can have ICH on initial presentation. The deep venous 
drainage and deep brain location of cAVM had higher incidence of ICH, a recurrent 
AVM hemorrhage of 12% over an average with an average rebleeding rate of 7% 
annually [15]. Pregnancy is not a risk factor for hemorrhage from a cAVM, but the 
data are not definitive [16]; cAVM hemorrhage rate in pregnant women was not 
significantly different compared with the rate for non-pregnant women [17].
7. Diagnosis
Imaging studies are essential for the establishment of the diagnosis of cAVM, to 
make a pre-therapeutic evaluation of the cAVM to help in decision-making, to treat 
the AVM as a sole therapy or a multidisciplinary approach. It also helps in post-
therapeutic evaluation of cAVM.
7.1 Computerized tomography (CT) of the brain
The CT of the brain is the first imaging procedure used to rule out hemorrhage. 
cAVM is suspected in young patients with lobar hematoma without significant 
oedema and calcifications. The parenchymal calcifications are found in 20% 
of cases, related to intravascular thrombosis or evolution of an old hematoma. 
Figure 3. 
Graphic representation of intracerebral hemorrhage.
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The compression of the nidus by hematoma precludes CT diagnosis of cAVM in 
patients with acute intracerebral hemorrhage; in these patients CT angiography and 
magnetic resonance angiography are essential.
7.2 Magnetic resonance imaging (MRI) of the brain
MRI of the brain is highly sensitive for the location of the cAVM nidus and an asso-
ciated draining vein; it also has a unique sensitivity in demonstrating remote bleeding 
related to these lesions. MRI of the brain is particularly valuable in follow-up patients 
after treatment. After radiosurgery MRI is important for the regression of the nidal 
volume. Whereas the MR angiography techniques can characterize the venous drainage 
and other vascular features, the surrounding tissue that is subjected to the radiation 
field can be accurately monitored for post-therapy oedema or radiation necrosis [18].
7.3 Cerebral angiography
It is the gold standard for the diagnosis, treatment planning and follow-up after 
treatment of cAVMs. The anatomical and physiological information of the cAVM 
nidus, its relationship to surrounding vessels and localization of the draining or 
efferent portion of the cAVM are readily obtained with this cerebral angiography. It 
will also help in demonstration of associated aneurysm suggesting a lesion at higher 
risk for subsequent hemorrhage. The contrast transit times provide additional use-
ful information regarding (Figure 4).
8. Treatment
The treatment plans of cAVM are most appropriately made by a multidisci-
plinary team of experienced clinicians with the consideration of size, location and 
vascular features of the AVM [19]. While making the decision, whether a patient 
should undergo AVM treatment, several factors have to be considered including the 
short- and long-term risk of hemorrhage, feasibility, associated aneurysm, patient’s 
age, risks of intervention, availability of interventional radiologist and size and 
compactness of the nidus. The short-term and long-term hemorrhage risk is associ-
ated with a history of raptured cAVM, patient age, AVM location, size and vascular 
morphological features.
Figure 4. 
Cerebral angiogram showing cAVM.
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The three types of modalities of treatment are microsurgery and excision of 
cAVM, embolization and stereotactic radiosurgery. It’s frequent that these modali-
ties are used in combination to achieve the complete treatment. In a systemic 
review, it was found that available treatment modalities were associated with risks 
including 5.1–7.4% of the median rate of permanent neurologic complications or 
death and incomplete efficacy of 13–96% [20]. Medical management of cAVM is 
considered when the patient has suffered a devastating neurological deficit; cAVM 
is very extensive, located deep in the brain, with blood supply primarily from 
deep perforating vessels, which are not amenable to endovascular or radiosurgical 
therapy, advanced age and poorly controlled comorbidities. We will discuss these 
modalities in the following subheadings.
8.1 Microsurgical cAVM excision
Microsurgical AVM excision is the most effective treatment of cAVM; it has 
the longest history of use for the definitive treatment of cAVMs and offers the 
best chance of immediate cure in patients at high risk of hemorrhage [19]. Factors 
associated with increased surgical risk are large size, deep venous drainage, deep 
location, diffuse nidus and feeders from deep perforating system. Surgeons 
should follow few basic surgical principles, cAVM excision should be an elec-
tive procedure, irrespective of the ruptured or unraptured cAVMs, preoperative 
steroids, anticonvulsants and antibiotics to be started, a wider craniotomy and 
dural opening, if the nidus is below the surface, an arterialized draining vein (red 
vein) can be followed to the AVM, localization may be assisted with ultrasound or 
frameless stereotaxic, dura should be open carefully, circumferential dissection 
of the nidus layer by layer, at least one major draining vein should be preserved 
till end of dissection, at end of dissection this vein becomes bluish proving that 
feeders have been eliminated, securing the individual vessels can be done with 
low power bipolar coagulation, but care should be taken as the excessive bipolar 
coagulation usage can cause retraction into eloquent tissue leading to the signifi-
cant neurological morbidity. The complete AVM excision should be documented 
by post-op angiogram. Excision of the whole nidus is necessary to protect against 
rebleeding. If cAVM are high-flow, preoperative embolization should be consid-
ered, and cAVM supplies with multiple vascular territories may require a surgical 
staging. If cAVM are ectatic, high blood flow and irregular vessels will help in the 
identification. The feeding arteries (Table 7) can be distinguished from draining 
veins not by sight or look, as the veins will have arterial blood but by noting if the 
distal vessel collapses with gentle occlusion of the vein. The surgeon should always 
secure the feeding artery as close to the nidus as possible to ensure that this is not 
a passage artery feeding the normal brain, unless there is definite evidence on an 
angiogram that an artery is a direct nidus feeder.
Size Vein dilates considerably, the vessel >4 mm is a vein unless proven otherwise
Color Due to oxygenated blood, both appear red, but on careful view under illumining microscopy, 
the vein appears bright red due to thin muscular layer, and the artery appears light pink
Flow on 
occlusion
Upon gentle compression of the vein, it will collapse distally unlike the artery
Vascular 
course
Arteries dive into sulci and fissure when veins rise to the surface towards sinuses
Table 7. 
Differentiation of the artery from the vein in cAVM.
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8.2 The morbidity and mortality of microsurgical excision of cAVMs
According to Castel and Kantor, morbidity and mortality after microsurgical 
excision of cAVM vary from 1.5 to 18.7% and from 0 to 15%, respectively [21]. 
Morbidity is high (20%) in deep-seated cAVM compared to the smaller cAVM with 
morbidity of up to 9% (Tables 8 and 9).
8.3 Stereotactic radiosurgery for cAVMs
High-energy beams of photons or protons to a defined volume containing 
cAVM nidus are stereotactically focused, and it induces progressive thrombosis of 
lesions by fibrointimal hyperplasia and subsequent luminal obliteration (Figure 5). 
The time between treatment and obliteration is referred to as the latency period, 
and it varies from 1 to 3 years. One has to wait for radiosurgery till the hematoma 
resolves. The factors influencing the obliteration rate of cAVM are cAVM size, 
target determination, angio-architecture and haemodynamics, cAVM location 
(hemispheric better) and radiation dosage. Stereotactic radiosurgery for cAVMs has 
disadvantages of the risk of hemorrhage in latency period and individual variability 
to radiosensitivity and neurological deficit.
The neurological deficit after radiosurgery is observed in 5.37% of the cases, 
and it was permanent in 1.46%. The mortality was 1.6%, and it is mainly due to the 
bleeding in the latency period [24].
The other complications after radiosurgery are radiation necrosis, which causes 
new neurologic deficits and seizures, and around 8% of the patients develop the 
parenchymal lesions, cranial nerve deficits, seizures, headaches and cyst formation 
[25]. The incidence of complications is related to cAVM location and the volume 
treated. Thalamic, basal ganglionic and brainstem locations are prone to develop-
ment of deficits after radiosurgery [26]. The risk of complications is also related to 
Intraoperative rupture
Post-retraction oedema
Seizures
Retrograde thrombosis of feeding vessels
Resection of eloquent brain
Normal perfusion pressure breakthrough (haemorrhage in normal brain tissue surrounding the lesion)
Table 8. 
Complication of microvascular surgery.
S-M grading Patient’s outcome
Grade I 92–100%
Grade II 95%
Grade III 88%
Grade IV 73%
Grade V 57%
(Heros RC, Korusure K, Diebuild PM.  Surgical excision if cerebral arteriovenous malformations. Neurosurgery. 
1990;26:570-577).
Table 9. 
Spetzler-Martin grading and patient’s outcome after microsurgery [22, 23].
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the radiation dose directed to the surrounding tissue and is increased in large brain 
AVMs that require larger treatment volumes [27]. Repeated radiosurgery is associ-
ated with increased complications [28].
8.4 Embolization
A rapidly evolving technique uses embolic agents such as silk, Histoacryl with 
Lipiodol and Onyx and delivery systems such as balloons with calibrated leaks, 
flow-guided micro-catheters and over-the-wire micro-catheters (Figure 6). It was 
used initially as an adjunct to microsurgery or radiosurgery; nowadays in selected 
cases, embolization is a sole treatment modality. By embolization less than 5% of 
cAVMs are cured.
Embolization can be an effective adjunct to radiosurgery and surgery. 
Embolization prior to radiosurgery is used to reduce the nidus size of large 
brain AVMs as the large AVMs have a lower cure rate with radiosurgery alone. 
Embolization prior to surgery is employed to reduce blood loss and to occlude 
Figure 5. 
Percentage of cAVM obliteration according to the nidus size (mm) by radiosurgery [25].
Figure 6. 
Embolization process.
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vessels that may be difficult to control during surgery [29]. Pre-embolization ste-
roids and anti-epileptic medications should be started; the procedure is done under 
general anesthesia. The aims of cAVM embolization could be curative or palliative, 
and it could be partial prior to the radio- or microscopic surgery. Careful analyses of 
angiographic information including size, eloquent location, deep versus superficial 
venous drainage and vascular anatomy/number of feeders are considered for the 
suitability for embolization of cAVMs.
The cAVM embolization can be complicated into partial occlusion, intracranial 
hemorrhage, brain ischemia, glueing of micro-catheter or perfusion pressure 
breakthrough syndrome. Perfusion pressure breakthrough syndrome occurs in 
approximately 5% of the patients, thought to be related to the loss of autoregulation 
causing oedema or hemorrhages in the surrounding normal brain tissues [30]. The 
successful cAVM embolization occurs in 10–40% of the patients and may have to be 
done in the multiple settings.
To summarize the treatment of cAVMs, the following factors have to be consid-
ered: the patient’s age and anatomic and vascular morphology of the cAVM.
8.5 Patient’s age
It is an important factor in the decision to treat cAVMs. Those with a longer life 
expectancy will accrue a higher lifetime risk of hemorrhage. Accordingly therapy is 
recommended for children and young adults, whereas the older cAVM patients with 
shorter life expectancies may be managed more conservatively. The cumulative risk 
of hemorrhage in cAVM patients can be calculated by the formula [31]: Lifetime risk 
of hemorrhage = 1 – (1 − P) × N (N is the expected years of life remaining, and P is 
the annual probability of hemorrhage). Another simpler formula is as follows: [32] 
Lifetime risk of hemorrhage = 105 - patient’s age in years.
8.6 cAVM location
cAVM in eloquent brain territories presents a challenge for risk assessment. 
Significant clinical morbidity is likely to result if a surgical complication occurs as 
well as if the cAVM ruptures. Such patients may be more likely to be considered for 
radiosurgery.
8.7 Deep venous drainage
Deep venous drainage is a risk factor for surgical complications as well as for 
AVM rupture. If the lesion is otherwise amenable for treatment, radiosurgery may 
be the best option.
8.8 The cAVM size
Larger lesions are more difficult to treat but are not clearly at higher risk of 
bleeding than smaller lesions. cAVMs greater than 6 cm are managed conserva-
tively. In patients with large lesions, the endovascular treatments may be useful 
to reduce the size of the aneurysm, if the vascular anatomy is determined to be 
amenable to this approach.
8.9 Associated aneurysm
The treatment of aneurysms associated with AVMs varies depending on aneu-
rysm location and diameter [33]. When believed to be the source of hemorrhage, 
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aneurysms are generally treated with surgery or endovascular therapy, depending 
on their location and size, according to the expertise of the available experienced 
clinicians. Aneurysms associated with unruptured cAVMs do not necessarily 
require treatment, depending on their size and other anatomic features.
Spetzler-Martin grading scale: Spetzler-Martin grading scale classifies surgical 
risk of removing cAVM according to its size, location and the presence of deep 
venous drainage. According to S-M grading, surgery is the modality of choice for 
grade I and II lesions, with radiosurgery as an alternative for small lesions based on 
location or other vascular anatomic features, while grade IV and V lesions are gener-
ally managed conservatively. S-M Supp grading gives a cut-off scale of 6 for opera-
bility of cAVM, and it is also a better predictor for post-cAVM excision neurological 
outcome. Hafez et al. [34] nicely described that apart from the S-M Supp grading, 
perforates play an important role in cAVM patient’s outcome (Table 10) [35].
9. Conclusion
Cerebral arteriovenous malformations are rare and 10 times less frequent than 
the cerebral aneurysms. cAVMs are rare in the posterior fossa and account for 33% 
of intracerebral hemorrhage in young patients. They are classified by four differ-
ent ways, but the commonly used classifications are Spetzler-Martin grading and 
supplementary Spetzler-Martin grading, as they also help in deciding the therapeu-
tic approach. But it is not much useful in dealing the posterior fossa cAVMs. cAVMs 
can complicate into the formation of flow-related aneurysms and, according to their 
locations in relation to the cAVM, are classified into intranidal, distal, proximal or 
unrelated aneurysms. Angio-structure of cAVM is the direct connection between 
arterial and venous circulations without any intervening capillary network, and this 
makes cAVM high in flow and pressure structure at the risk of rapture.
The common presentation of cAVM is with intracerebral hemorrhage, with con-
vulsions and rarely with focal neurological deficit. The most commonly used imag-
ing modality for the diagnosis of cAVMs is computerized tomography. MRI scan 
has a unique sensitivity for the detection of remote hemorrhage, and conventional 
catheter cerebral angiography remained a gold standard in diagnosis of cAVMs. 
Multidisciplinary team approach is the best for management of cAVM patients. The 
surgical excision of cAVM gives definitive therapy in cAVM patients, radiosurgery 
is curative in selected cAVM patients and cerebral angiographic embolization is 
Microsurgery Radiosurgery Embolization
Low procedural invasivity 1 3 2
Occlusion capacity 3 2 1–2
Speed of efficacy 3 1 2–3
Long-term reliability 3 3 2–3
Independent from size 2 1 3
Independent from brain functionality 1 2 3
Independent from angio-architecture 2 3
Independent from flow 3 2 1
1: no/low, 2: medium, and 3: yes/high.
Table 10. 
Factors for selecting the modalities of therapy in cAVM patients [34].
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rarely a sole therapy and usually in combination with surgical therapy. The medical 
therapies of cAVM are anticonvulsants and steroids. While taking a therapeutic 
decision for cAVMs, it is of vital importance to consider the patient’s age, location, 
deep venous drainage, size of cAVMs and the presence of the associated aneurysms. 
The associated aneurysms must be secured before the interventions for cAVMs.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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